Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$651,907,057
+$91,575,653 QoQ
Shares Held
2,666,941
-1.5% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 64.46536017544847.ToString("F0")%
Shared 1.9590729598180534.ToString("F0")%
None 33.57556686473349.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$2,836,926
PutShares
15,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Corient Private Wealth LLC holds $2,531,352,954 across 16 Drug Manufacturers - General names. JNJ ranks #1 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,666,941 | $651,907,057 | |
| 2 | LLY |
ELI LILLY & Co
|
654,787 | $602,253,438 | |
| 3 | ABBV |
AbbVie Inc.
|
2,203,650 | $479,271,837 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,428,276 | $292,097,319 | |
| 5 | AMGN |
Amgen Inc
|
550,867 | $193,822,553 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
619,389 | $86,324,244 | |
| 7 | PFE |
Pfizer Inc
|
2,558,429 | $71,840,686 | |
| 8 | NVS |
Novartis AG
|
440,526 | $67,290,346 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $651,907,057 | 2,666,941 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $560,331,404 | 2,707,569 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $2,836,926 | 15,300 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $481,588,397 | 2,597,284 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $341,798,745 | 2,237,635 | Shares | Other | 2025-09-26 | |
| 2025-03-31 | $370,953,066 | 2,236,813 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $355,028,069 | 2,454,903 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $453,091,560 | 2,795,826 | Shares | Other | 2024-11-12 | |
| 2024-09-30 | $2,463,312 | 15,200 | Put | Sole | 2024-11-12 | |
| 2024-06-30 | $392,021,436 | 2,682,139 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $444,407,437 | 2,809,327 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $442,562,129 | 2,823,543 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $420,028,624 | 2,696,813 | Shares | Other | 2023-11-03 | |
| 2023-09-30 | $2,476,425 | 15,900 | Put | Sole | 2023-11-03 | |
| 2023-06-30 | $437,277,686 | 2,641,842 | Shares | Other | 2023-08-10 | |
| 2023-03-31 | $411,280,410 | 2,653,422 | Shares | Other | 2023-05-15 | |
| 2023-03-31 | $2,464,500 | 15,900 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $2,808,735 | 15,900 | Put | Sole | 2023-02-15 | |
| 2022-12-31 | $330,334,263 | 1,869,993 | Shares | Other | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||